Phase I trial in participants with rheumatoid arthritis and healthy volunteers with CIT-013, a first-in-class extracellular traps targeted therapy.
- DOI
- 10.1016/j.ero.2026.03.018
- Published
- 2026 Jun
- Container
- EULAR rheumatology open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ero.2026.03.018,
title = {Phase I trial in participants with rheumatoid arthritis and healthy volunteers with CIT-013, a first-in-class extracellular traps targeted therapy.},
author = {Ronner MN and Klarenbeek NB and Hadi S and Middelink LM and Kraan MC},
year = {2026},
journal = {EULAR rheumatology open},
doi = {10.1016/j.ero.2026.03.018},
url = {https://doi.org/10.1016/j.ero.2026.03.018}
}RIS
TY - JOUR TI - Phase I trial in participants with rheumatoid arthritis and healthy volunteers with CIT-013, a first-in-class extracellular traps targeted therapy. AU - Ronner MN AU - Klarenbeek NB AU - Hadi S AU - Middelink LM AU - Kraan MC PY - 2026 JO - EULAR rheumatology open DO - 10.1016/j.ero.2026.03.018 UR - https://doi.org/10.1016/j.ero.2026.03.018 ER -
APA
MN, R., NB, K., S, H., LM, M., & MC, K. (2026). Phase I trial in participants with rheumatoid arthritis and healthy volunteers with CIT-013, a first-in-class extracellular traps targeted therapy.. EULAR rheumatology open. https://doi.org/10.1016/j.ero.2026.03.018
Source records
- pubmed · retrieved 2026-09-26T08:53:11.969Z